LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible ), a Research & Development company committed to scientific innovation for ...
The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...
23 Member and Associate States of the Agency pledged a total 117.6 million euros to ESA’s ScaleUp programme at ESA’s Ministerial Council CM22 to encourage entrepreneurship and commercialisation in the ...
QuantumScape is rated a buy, driven by the first shipment of QSE-5 B1 samples, marking a key commercialization milestone. QS's collaboration with Volkswagen's PowerCo and successful real-world ...